Capital Edge of Kuwait to invest USD 1 bn in NexGen Energia

Green energy firm NexGen Energia on Monday said regional investment behemoth Capital Edge of Kuwait will invest USD 1 billion in it to expand its infrastructure in India. The equity-based funding will enable NexGen Energia, India's leading installer of Compressed Bio-Gas (CBG) plants, to expand its CBG infrastructure across the country, supporting India's shift to clean energy and energy self-reliance, a company statement said. According to the statement, reflecting increasing global faith in India's renewable energy industry, green energy firm NexGen Energia Ltd has pledged USD 1 billion from Capital Edge of Kuwait. This strategic infusion represents a sea change for NexGen Energia, which has emerged as an increasingly important contributor to India's clean energy movement, it stated. Noida-based NexGen Energia has led the way in India's transition to renewable and alternative forms of energy. One of its crown jewel programmes is the building out of Compressed Bio-Gas infrastructure - a cleaner, sustainable alternative to fossil fuels. With the support of Capital Edge, the firm will be able to grow its operations exponentially. The USD 1 billion (approximately Rs 850 crore) equity infusion will be fully utilised in the deployment and operation of CBG plants, making the company's vision of sustainable innovation a reality.
"This capital infusion marks a pivotal moment in our journey. It will accelerate our vision to build a greener India through scaled-up CBG production. We're excited about the environmental and social impact this will create across the country," Nishant Tiwari, Director Sales at NexGen Energia, said. Early projects will be launched in high-potential areas such as Maharashtra, Uttar Pradesh, and Karnataka, with land acquisition and vendor associations already progressing.
The next 18-24 months are planned by the company to finish a number of CBG facilities, with a scaled rollout extending through 2026. The vision also extends to include supply chain integration, technology innovation, and community involvement for long-term sustainability of the project.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

News18

24 minutes ago

• News18

Influx Healthtech IPO Allotment: A Step-By-Step Guide To Check Status Online Today, Know Latest GMP

Last Updated: According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. Influx Healthtech IPO Allotment: The initial public offering of Influx Healthtech has received a whopping 201.35 times subscription, indicating huge interest from investors. Investors are now eagerly awaiting its allotment even its latest GMP shows a strong 22.92% listing gains. The allotment of the Influx Healthtech IPO is expected to be finalised today, Monday, June 23, in the evening. Once the IPO allotment is finalised, investors will start receiving bank debit messages, most probably in the evening. They can also check their allotment status on the websites of the NSE as well as registrar Maashitla Securities Private Limited. The allotment is expected to be finalised in the evening today, Friday, June 20. The allotment status can be checked by following these steps: Step 1: Visit Maashitla Securities' portal — Step 2: Under 'Select Company', choose 'Influx Healthtech Ltd'. Importantly, if the company's name is not visible in the drop-down list, it means the allotment has not been finalised yet. According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Influx Healthtech IPO Listing Date The shares of Influx Healthtech Ltd will be listed on the NSE Emerge on June 25. The Influx Healthtech IPO was open for subscription between June 18 and June 20. It is a book-built issue worth Rs 58.57 crore, comprising a fresh issue of 50 lakh equity shares worth Rs 48 crore and an offer for sale of 11 lakh shares aggregating to Rs 10.56 crore. On the final day of bidding on Friday, the SME IPO received an overwhelming 201.35 times subscription, garnering bids for 81,71,71,200 shares as against 40,58,400 shares on offer. The retail and NII participation stood at 117.68 times and 481.10 times, respectively. Its qualified institutional buyer (QIB) category got a 137.87 times subscription. The price of the Influx Healthtech IPO was fixed at Rs 96 apiece. Influx Healthtech Ltd's revenue increased 5% and its profit after tax (PAT) rose 19% between the financial year ending with March 31, 2025, and March 31, 2024. Rarever Financial Advisors Pvt Ltd is the book-running lead manager of the Influx Healthtech IPO, while Maashitla Securities Private Limited is the registrar for the issue. The market maker for Influx Healthtech IPO is R K Stock Holding Private Limited. Influx Healthtech Ltd, founded in September 2020, is a healthcare-focused CDMO with three manufacturing units in Thane, producing tablets, capsules, powders, liquid orals, and softgels.

Time of India

26 minutes ago

• Time of India

Orders soar for Taiwan cleanroom firms amid global chip industry expansion

Much of this growth is tied to TSMC's massive investment of $65 billion in three chip factories, known as "fabs," in Arizona. The first fab has already started mass production, and the second is nearly finished. With a total order backlog of NTD (New Taiwan dollar) 132.27 billion ($4.45 billion), UIS is expected to receive even more orders later in 2025. Experts predict the company will have its highest-ever sales in 2025. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Taiwanese cleanroom companies are receiving a wave of new orders as major global chipmakers expand production around the world, especially in the United States and Southeast Integrated Services Co. (UIS), a longtime supplier to Taiwan Semiconductor Manufacturing Co. (TSMC), is one of the main winners in this January to May 2025, UIS secured NTD (New Taiwan dollar) 83.68 billion ($2.57 billion) in cleanroom-related contracts -- a new record for the of this growth is tied to TSMC's massive investment of $65 billion in three chip factories, known as "fabs," in Arizona. The first fab has already started mass production, and the second is nearly a total order backlog of NTD 132.27 billion ($4.45 billion), UIS is expected to receive even more orders later in 2025. Experts predict the company will have its highest-ever sales in 2025.L&K Engineering Co., another major cleanroom provider, is also seeing strong demand. It reported NTD 95.76 billion (USD 3.23 billion) in new orders in the first five months of the year, largely from Taiwanese firms building new fabs in Southeast Asia.L&K now has a total backlog of NTD 208.49 billion ($7.02 billion). Some of this comes from projects with United Microelectronics Corp. (UMC), which recently opened a new fab in there will start in 2026. L&K is also working with Vanguard International Semiconductor Corp., which is building a 12-inch fab in Singapore with Dutch company NXP Semiconductors. That plant will start production in Taiwanese firms like Acter Group Corp. and Yankey Engineering Co. are also doing well. Acter now holds over NTD 46 billion ($1.55 billion) in orders, up from NTD 38 billion ($1.28 billion) at the end of 2024, helped by business from chip packaging company Siliconware Precision Industries Engineering has NTD 40.67 billion ($1.37 billion) in orders, supported in part by Dutch equipment maker ASML's expansion in are a critical part of chipmaking. They remove dust and other particles that could damage delicate components during production. As chip companies grow worldwide, demand for these high-tech spaces is rising -- and Taiwanese firms are leading the way.

India.com

27 minutes ago

• India.com

Good news for Anil Ambani, another company settles Rs 2730000000 loan of…, with…

Anil Ambani was already in the news for settling down the debt of his many companies. Now once again it has settled the debt with another company. In a recent exchange filing it stated that it has fully settled a Rs 273-crore loan, including interest, owed by its wholly owned subsidiary JR Toll Road Pvt Ltd (JRTR) to Yes Bank Ltd. It stated, '' A wholly owned subsidiary of the Company (along with the Company as Corporate Guarantor), has entered into an addendum to the Settlement Agreement today with Yes Bank Limited (YBL) for the entire outstanding debt obligation of ~INR 273 crore (including interest) owed by JRTR to YBL, and has duly paid the entire settlement amount.'' Anil Ambani Company Debt Reduction Debt reduction has become a primary focus for Anil Ambani. Reliance Infrastructure: Paid off Rs 3,300 crore of debt in FY 2025, becoming debt-free. Rosa Power Supply Company: Cleared Rs 485 crore of debt, achieving debt-free status. Reliance Power: Settled a loan of Rs 3,872 crore earlier. JR Toll Road Pvt Ltd, a special purpose vehicle established by Reliance Infrastructure, is responsible for the development, operation, and maintenance of a 52-kilometer segment of National Highway 11, connecting Jaipur and Reengus in Rajasthan. The project was executed under the Design-Build-Finance-Operate-Transfer (DBFOT) model, featuring a highway expansion from four to six lanes. Operations commenced in 2013, coinciding with the start of toll collection.